Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 6, 2018
Albireo to Present at 38th Annual Cowen and Company Health Care Conference
BOSTON, March 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 6, 2018
Achaogen to Present at the Cowen and Company 38th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
March 6, 2018
Acer Therapeutics to Present at the 30th Annual ROTH Conference
NEWTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
March 5, 2018
ADMA Biologics Reports Full Year 2017 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
March 5, 2018
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for its Inter-Alpha-Inhibitor-Proteins
LAVAL, QC, March 5, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF)("Prometic") today announced that the U.S Food and Drug Administration (FDA) has granted a Rare ...
March 5, 2018
Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting
PALO ALTO, Calif., March 5, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., (EIGR) today announced that abstracts from its LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta ...
March 5, 2018
BioTime to Announce Fourth Quarter and Fiscal 2017 Results on March 15, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that ...
March 5, 2018
BrainStorm to Host an Annual Financial Results Call and Provide a Corporate Update on Thursday, March 8
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 5, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
March 5, 2018
Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
March 5, 2018
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
TEL AVIV, Israel, March 5, 2018 /PRNewswire/ --Kitov Pharmaceuticals (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that it filed its Annual Report ...
March 5, 2018
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
March 5, 2018
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 1, 2018
Basilea names Adesh Kaul as new member of its Management Committee
Basel, Switzerland, March 01, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer ...
March 1, 2018
iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution
VIENNA, Austria, March 01, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global leader in medical technology providing innovative cancer detection and therapy solutions, today ...
March 1, 2018
BIOPHYTIS updates on SARA clinical study of Sarconeos in sarcopenia and presents four posters at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Miami
PARIS, March 01, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, ...
March 1, 2018
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
March 1, 2018
CytoSorbents to Report Fiscal 2017 Operating and Financial Results
MONMOUTH JUNCTION, N.J., March 1, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill ...
March 1, 2018
Arena Pharmaceuticals to Present Phase 1 and Preclinical Data on APD371 in Development for Treatment of Pain Associated with Crohn's Disease at American Pain Society Annual Scientific Summit
SAN DIEGO, March 1, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), will present Phase 1 and preclinical data for the investigative drug candidate APD371 at the ...
March 1, 2018
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the fourth quarter and ...
March 1, 2018
Achaogen Enters Into New $50 Million Secured Credit Facility with Silicon Valley Bank
SOUTH SAN FRANCISCO, Calif., March 1, 2018 /PRNewswire/ -- Achaogen, Inc.(AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, has entered ...
Page 61 of 117